[NMusers] Two Positions at Merck Pharmacometric Department in Darmstadt and Lausanne

From: Pascal Girard <pascal.girard_at_merckgroup.com>
Date: Mon, 17 Oct 2016 15:23:57 +0000

Dear NMUSER,

Merck is seeking two creative, motivated scientists to join our Pharmacomet=
ric department as Senior Scientists, one in Darmstadt, Germany (https://ca=
reer012.successfactors.eu/career?company=merckgroup Req Id 147355) and =
one in Lausanne, Switzerland (Req Id 151627).

As the biopharma business of Merck, we have an enduring commitment to trans=
form lives through innovative medicines and high-value solutions. We focus =
on areas of high unmet medical needs and are a leader in providing differen=
tiated medicines to help improve patient outcomes in key areas such as canc=
er, multiple sclerosis, infertility, endocrine and metabolic disorders. Wit=
h headquarter in Darmstadt, Germany, we're active on all continents and of=
fer leading brands in 150 countries. In the United States and Canada we ope=
rate under the name EMD Serono through separately incorporated affiliates.

YOUR ROLE
Pharmacometric Department, part of GED/QPD/QP, contributes to clinical deve=
lopment efficiency by providing core expertise modeling in the quantificati=
on of the relationship between dose, exposure and response, and factors aff=
ecting its variability. As senior pharmacometrician, you will have to elabo=
rate, design, execute/supervise and report pharmacokinetic/pharmacodynamic =
(PK/PD) and modeling and simulation analysis in order to support model info=
rmed drug development discovery, in collaboration with pharmacology, clinic=
al and biostatistics teams. As an experienced scientist, you will also keep=
 up-to-date with scientific development in PK/PD and share your own experti=
se with pharmacometric colleagues

WHO YOU ARE
- PhD, MD, PharmD or Master with 4+ years of experience in PK/PD Modeling, =
of which 2+ in (Bio)Pharmaceutical Industry
- NONMEM and R experience is a requisite;
- experience with XPose, PsN, MONOLIX, SIMULX, SIMCYP, etc would be a good =
asset
- Communicate technical results and details effectively with scientists and=
 clinicians
-At ease in working in a dynamic matrix organization; is a team-player
- Fluent in speaking and writing English; fluency in other European languag=
es, particularly German or French, is an asset

To apply to the Darmstadt position, please visit the careers pages on htt=
ps://career012.successfactors.eu/career?company=merckgroup and enter th=
e Requisition ID: 147355.

To apply to the Darmstadt position, please visit the careers pages on htt=
ps://career012.successfactors.eu/career?company=merckgroup and enter th=
e Requisition ID: 151627.

With best regards,

Pascal Girard
Director, Head of Pharmacometry

Merck

Merck Institute for Pharmacometrics,
EPFL Innovation Park - Building I, CH-1015 Lausanne, Switzerland
Email: pascal.girard_at_merckgroup.com<mailto:pascal.girard_at_merckgroup.com> | =
www.merckgroup.com<http://www.merckgroup.com>
Mandatory information can be found at: http://www.merckgroup.com/mandatorie=
s



This message and any attachment are confidential and may be privileged or o=
therwise protected from disclosure. If you are not the intended recipient, =
you must not copy this message or attachment or disclose the contents to an=
y other person. If you have received this transmission in error, please not=
ify the sender immediately and delete the message and any attachment from y=
our system. Merck KGaA, Darmstadt, Germany and any of its subsidiaries do n=
ot accept liability for any omissions or errors in this message which may a=
rise as a result of E-Mail-transmission or for damages resulting from any u=
nauthorized changes of the content of this message and any attachment there=
to. Merck KGaA, Darmstadt, Germany and any of its subsidiaries do not guara=
ntee that this message is free of viruses and does not accept liability for=
 any damages caused by any virus transmitted therewith.



Click http://www.merckgroup.com/disclaimer to access the German, French, Sp=
anish and Portuguese versions of this disclaimer.

Received on Mon Oct 17 2016 - 11:23:57 EDT

This archive was generated by hypermail 2.3.0 : Fri Sep 27 2019 - 16:52:13 EDT